Stevens First Principles Investment Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-500	Closed	-$35K	–	196
2015 Q4	$35K	Sell	500 -300	-38%	-$24.4K	0.03%	120
2015 Q3	$73K	Buy	+800	New	+$89K	0.06%	105

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stevens First Principles Investment Advisors's GWPH Position: Q1 2016 in Review

Stevens First Principles Investment Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2016, closing a stake of 500 shares — an estimated $35K sold.

Stevens First Principles Investment Advisors first reported a position in GWPH in Q3 2015 and held it in 2 quarters. The position peaked at $73K in Q3 2015. 108 funds tracked by Wall St. Rank hold GWPH as of Q1 2016.

Stevens First Principles Investment Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2016 after selling out during the quarter.
Stevens First Principles Investment Advisors sold 500 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2016, an estimated $35K.
Stevens First Principles Investment Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 2 quarters.
Stevens First Principles Investment Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $73K in Q3 2015.
108 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2016.

Based on Stevens First Principles Investment Advisors's 13F filing for Q1 2016, filed 13 May 2016.